9. Where Can I Find More Information About This Study?
Amgen has committed to make research results available to the public. This summary has
been provided as part of that commitment and should not be used for any other purpose. It
should not be considered to make a claim for any product or to guide treatment decisions.
Some information in this summary may be different from the approved labeling for
etanercept. Your healthcare professional should refer to the full prescribing information for
proper use of etanercept.
To find out more about this study, check these websites:
 www.clinicaltrials.gov. Use the study identifier NCT02376790
 www.clinicaltrialsregister.eu. Use the study identifier 2014-004869-24
More information is also available in this publication:
Mease PJ, Gladman DD, Collier DH, Ritchlin CT, Helliwell PS, Liu L, Kricorian G, Chung JB.
Etanercept and methotrexate as monotherapy or in combination for psoriatic arthritis:
primary results from a randomized, controlled phase 3 trial. Arthritis Rheum. 2019; 71 (7):
1112-1124.
devorppA
If you participated in the study and have questions about the study results, the doctor or staff
at your study site may be able to answer them.
12